22 structural-engineering "https:" "https:" "https:" "https:" "https:" "https:" "Dip" uni jobs at Fred Hutchinson Cancer Center
Sort by
Refine Your Search
-
stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. The Systems Engineer IV (SE IV) is a technical leader within the Systems Engineering team
-
treatment outcomes. The incumbent will perform functions requiring knowledge and skills specific to the program studies and to clinical research. Faculty Members' websites: Catherine Liu, MD: https
-
stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. With general guidance, the Systems Engineer III (SE III) is expected to ensure the stability
-
. Further information on Dr. Talbot's research can be found at: https://www.fredhutch.org/en/faculty-lab-directory/talbot-jhimmy.html The candidate must be able to work 12 hours per week on three different
-
treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide. Connections working at Fred Hutchinson Cancer Center More Jobs from This Employer https
-
Hutchinson Cancer Center More Jobs from This Employer https://main.hercjobs.org/jobs/21755391/program-head-phase-i-clinical-trials Return to Search Results
-
& impact in a variety of dimensions including cutting edge clinical trial operations, process improvement, technology tools and data-driven decision making. This is a full-time, salaried position
-
% of time. Qualifications Required: Bachelors or Associates Degree in Radiation Therapy Registered in Radiation Technology by the American Registry of Radiologic Technologists Washington State License
-
aptitude to quickly learn new systems and applications, and able to apply technology to improve systems and processes. Superior organizational skills and must be detailed. Strong computer and word processing
-
tumors using engineered T cells. Our focus is on using helper CD4 T cells to target immune stimulatory cells to the tumor immune microenvironment to reverse immune suppression and enable tumor rejection